Levalbuterol

Levalbuterol ((R) -Albuterol; (R) -Salbutamol) is a short-acting β2-adrenergic receptor agonist and the active (R) -enantiomer of Salbutamol. Levalbuterol is a more potent bronchodilator than Salbutamol and has the potential for the treatment of COPD[1].

Product Specifications

CAS Number

[34391-04-3]

Product Name Alternative

(R) -Albuterol; (R) -Salbutamol; Levosalbutamol

UNSPSC

12352005

Hazard Statement

H302-H312-H332

Target

Adrenergic Receptor

Type

Reference compound

Related Pathways

GPCR/G Protein; Neuronal Signaling

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/levalbuterol.html

Solubility

10 mM in DMSO

Smiles

CC(C)(NC[C@@H](C1=CC=C(C(CO)=C1)O)O)C

Molecular Formula

C13H21NO3

Molecular Weight

239.31

Precautions

P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P363-P501

References & Citations

[1]Randall MJ, et al. Anti-inflammatory effects of levalbuterol-induced 11β-hydroxysteroid dehydrogenase type 1 activity in airway epithelial cells.Front Endocrinol (Lausanne) . 2015 Jan 12;5:236.|[2]Ferrada MA, et al. (R) -albuterol decreases immune responses: role of activated T cells.Respir Res. 2008 Jan 14;9:3.